Hematology/Oncology Clinics of North America - Volume 32: Castleman Disease Pathogenesis

Elsevier, Hematology/Oncology Clinics of North America, Volume 32, Issue 1, February 2018, Pages 11-21
Authors: 
David C. Fajgenbaum and Dustin Shilling

Establishes the nomenclature required to discuss the different subtypes of CD and provides a summary of current understanding of the cause, cell types, signaling pathways, and effector cytokines implicated in pathogenesis.

Read on ScienceDirect
Show previous page

Special issue

Category:

Book chapters

Tags:

Health and population; Health and wellbeing; Global

Related content

Long-term air pollution exposure and incident physical disability in older US adults: a cohort study
Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework
Ear disease, hearing loss, and cognitive outcomes in high school children who were previous participants in a randomized placebo controlled trial of an 11 valent conjugate pneumococcal vaccine administered in infancy
Towards an agenda of action and research for making health systems responsive to the needs of people with disabilities
Food insecurity in households with persons with disabilities in a situation of extreme vulnerability in Brazil: A secondary cross-sectional analysis